- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.88 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NAP.3: 26 residues within 4Å:- Chain A: Y.25, G.26, S.27, Q.28, I.47, R.48, S.52, V.66, L.79, L.80, P.81, D.82, I.84, Q.85, V.88, A.106, H.107, P.129, G.131, P.132, G.133
- Chain B: S.249, I.250, S.251
- Ligands: E9G.4, E9J.5
30 PLIP interactions:25 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:Q.28
- Hydrogen bonds: A:Y.25, A:Y.25, A:S.27, A:Q.28, A:Q.28, A:R.48, A:R.48, A:S.52, A:S.52, A:S.52, A:L.80, A:D.82, A:Q.85, A:G.133, B:S.249, B:I.250
- Water bridges: A:G.26, A:S.27, A:S.27, A:G.29, A:R.48, A:R.48, A:R.51, A:H.107, B:S.251, B:N.252, B:N.252
- Salt bridges: A:R.48
- pi-Cation interactions: A:R.48
NAP.10: 25 residues within 4Å:- Chain A: S.249, I.250, S.251
- Chain B: G.24, Y.25, G.26, S.27, Q.28, I.47, R.48, S.52, L.79, L.80, P.81, D.82, Q.85, V.88, A.106, H.107, P.129, G.131, P.132, G.133
- Ligands: E9G.6, E9J.7
28 PLIP interactions:3 interactions with chain A, 25 interactions with chain B- Hydrogen bonds: A:S.249, B:Y.25, B:Y.25, B:S.27, B:S.27, B:S.27, B:Q.28, B:Q.28, B:R.48, B:R.48, B:S.52, B:S.52, B:L.80, B:D.82, B:Q.85, B:G.133
- Water bridges: A:N.252, A:N.252, B:G.26, B:G.29, B:R.48, B:R.48, B:G.50, B:F.53, B:H.107
- Hydrophobic interactions: B:Q.28
- Salt bridges: B:R.48
- pi-Cation interactions: B:R.48
- 2 x E9G: {hydroxy[(1S)-1-phenylethyl]amino}(oxo)acetic acid(Non-covalent)
E9G.4: 14 residues within 4Å:- Chain A: P.132, D.190, E.194, L.198
- Chain B: E.230, I.234, S.249, I.250, S.251, A.254
- Ligands: MG.1, MG.2, NAP.3, E9J.5
14 PLIP interactions:6 interactions with chain B, 8 interactions with chain A- Hydrophobic interactions: B:E.230, B:I.234, B:I.234, B:I.250, A:L.198, A:L.198
- Hydrogen bonds: B:S.251, A:E.194
- Water bridges: B:S.251, A:K.130, A:D.190, A:D.190, A:D.190, A:E.194
E9G.6: 14 residues within 4Å:- Chain A: E.230, L.233, I.234, L.237, I.250, S.251, A.254
- Chain B: P.132, D.190, E.194
- Ligands: E9J.7, MG.8, MG.9, NAP.10
14 PLIP interactions:7 interactions with chain B, 7 interactions with chain A- Hydrophobic interactions: B:P.132, B:P.132, A:L.233, A:L.237, A:A.254
- Water bridges: B:P.129, B:K.130, B:K.130, B:E.194, B:E.194, A:E.230, A:E.230, A:S.251
- Hydrogen bonds: A:S.251
- 2 x E9J: oxo{[(1S)-1-phenylethyl]amino}acetic acid(Non-covalent)
E9J.5: 14 residues within 4Å:- Chain A: P.132, D.190, E.194, L.198
- Chain B: E.230, I.234, S.249, I.250, S.251, A.254
- Ligands: MG.1, MG.2, NAP.3, E9G.4
9 PLIP interactions:6 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:E.230, B:I.234, B:I.234, A:L.198, A:L.198
- Hydrogen bonds: B:E.230, B:S.251
- Water bridges: B:S.251, A:K.130
E9J.7: 14 residues within 4Å:- Chain A: E.230, L.233, I.234, L.237, I.250, S.251, A.254
- Chain B: P.132, D.190, E.194
- Ligands: E9G.6, MG.8, MG.9, NAP.10
12 PLIP interactions:5 interactions with chain B, 7 interactions with chain A- Hydrophobic interactions: B:P.132, B:P.132, A:L.233, A:L.237, A:I.250, A:A.254
- Water bridges: B:K.130, B:E.194, B:E.194, A:S.251
- Hydrogen bonds: A:E.230, A:S.251
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kandale, A. et al., Design, synthesis, in vitro activity and crystallisation of novel N-isopropyl-N-hydroxyoxamate derivatives as ketol-acid reductoisomerase (KARI) inhibitors. To Be Published
- Release Date
- 2018-12-12
- Peptides
- Ketol-acid reductoisomerase (NADP(+)): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.88 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x E9G: {hydroxy[(1S)-1-phenylethyl]amino}(oxo)acetic acid(Non-covalent)
- 2 x E9J: oxo{[(1S)-1-phenylethyl]amino}acetic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kandale, A. et al., Design, synthesis, in vitro activity and crystallisation of novel N-isopropyl-N-hydroxyoxamate derivatives as ketol-acid reductoisomerase (KARI) inhibitors. To Be Published
- Release Date
- 2018-12-12
- Peptides
- Ketol-acid reductoisomerase (NADP(+)): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B